Zobrazeno 1 - 10 of 10 pro vyhledávání: '"F J, Brescia"'
1
Pain, opioid use, and survival in hospitalized patients with advanced cancer
Autor: L Krasnoff, F J Brescia, M Ryan, G Gray, R K Portenoy
Publikováno v: Journal of Clinical Oncology. 10:149-155
PURPOSE Pain is a common and feared symptom for patients with incurable cancer. Comprehensive assessment provides the foundation for effective pain management, and data that clarify the relationship between pain and other relevant factors also facili
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33813627ef00e456ca4e5f32b5a5e158
https://doi.org/10.1200/jco.1992.10.1.149
Zobrazit plný text záznamu
2
Irinotecan/gemcitabine combination chemotherapy in pancreatic cancer
Autor: C M, Rocha Lima, C A, Sherman, F J, Brescia, C Y, Brunson, M R, Green
Publikováno v: Oncology (Williston Park, N.Y.). 15(3 Suppl 5)
Gemcitabine (Gemzar) and irinotecan (CPT-11, Camptosar) are active cytotoxic drugs against pancreatic cancer. Preclinical data evaluating the combination of gemcitabine and irinotecan suggest dose-dependent synergistic interactions in SCOG small-cell
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a0978b8e6ccd39a17302e1b38ed56d16
https://pubmed.ncbi.nlm.nih.gov/11301841
Zobrazit plný text záznamu
3
Docetaxel followed by gemcitabine and irinotecan in solid tumors
Autor: C M, Rocha Lima, J J, Urbanic, C A, Sherman, F J, Brescia, M R, Green
Publikováno v: Oncology (Williston Park, N.Y.). 15(1 Suppl 1)
Docetaxel (Taxotere), gemcitabine (Gemzar), and irinotecan (Camptosar, CPT-11) are active single agents in a variety of solid tumors. In combination, synergism may be schedule dependent. Preclinical studies suggested synergistic interactions when doc
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a756dbcf7f388cc5374d149adee098e0
https://pubmed.ncbi.nlm.nih.gov/11221020
Zobrazit plný text záznamu
4
Irinotecan in the management of patients with pancreatic cancer
Autor: M R, Green, M, Harper, A, Safa, C A, Sherman, C M, Mushtaq, H, Bahadori, F J, Brescia, C M, Rocha Lima
Publikováno v: Oncology (Williston Park, N.Y.). 14(12 Suppl 14)
Synergy with no overlapping toxicities has been demonstrated for the combination of irinotecan (Camptosar, CPT-11) and gemcitabine (Gemzar) in vitro. Results of a single-institution phase I study in which patients with previously untreated pancreatic
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::664f5d2b81b0f2578a52d62db6cf56fb
https://pubmed.ncbi.nlm.nih.gov/11200146
Zobrazit plný text záznamu
8
Meta-analysis of neurokinin-1 receptor antagonists (NK-1 RA) for chemotherapy-induced nausea and vomiting (CINV)
Autor: Eduardo Bruera, I. W. Tremont-Lukats, J. Gonzalez-Barboteo, F. J. Brescia
Publikováno v: Journal of Clinical Oncology. 22:8047-8047
8047 Background: CINV remains a problem for many patients treated with highly emetogenic chemotherapy. NK1 RAs are antiemetics that could improve CINV prophylaxis. We evaluated the effectiveness of NK1 RAs to completely control acute and delayed CINV
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9edec40cbf441acf3a495418e834ab62
https://doi.org/10.1200/jco.2004.22.90140.8047
Zobrazit plný text záznamu
10
Reason, courage, and grace: notes of a death watcher
Autor: F J, Brescia
Publikováno v: Health progress (Saint Louis, Mo.). 66(2)
Dying is strikingly private and personal, and it breaks the interconnectedness of all human life. It is at such a time that the physician's humanity must touch the unique personhood of the afflicted if the death is to be "good". A physician's duty do
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::472524d0371adb711307b5765d0f9ec7
https://pubmed.ncbi.nlm.nih.gov/10270329
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje